Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition by Canna, Scott W., MD, Girard, Charlotte, MD, Malle, Louise, BS, de Jesus, Adriana, MD, PhD, Romberg, Neil, MD, Kelsen, Judith, MD, Surrey, Lea F., MD, Russo, Pierre, MD, Sleight, Andrew, PhD, Schiffrin, Eduardo, MD, Gabay, Cem, MD, Goldbach-Mansky, Raphaela, MD, MHS, Behrens, Edward M., MD

Get full text

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial by Gabay, Cem, MD, Emery, Paul, MD, van Vollenhoven, Ronald, MD, Dikranian, Ara, MD, Alten, Rieke, MD, Pavelka, Karel, MD, Klearman, Micki, MD, Musselman, David, MD, Agarwal, Sunil, MD, Green, Jennifer, MSc, Kavanaugh, Arthur, Dr

Get full text

Reply by Canna, Scott W., MD, Girard, Charlotte, MD, Malle, Louise, BS, de Jesus, Adriana, MD, PhD, Romberg, Neil, MD, Kelsen, Judith, MD, Surrey, Lea F., MD, Russo, Pierre, MD, Sleight, Andrew, PhD, Schiffrin, Eduardo, MD, Gabay, Cem, MD, Goldbach-Mansky, Raphaela, MD, MHS, Behrens, Edward M., MD

Get full text